Docetaxel and Ramipril drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Docetaxel (docetaxel) and Ramipril (ramipril). Common drug interactions include nausea among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Docetaxel and Ramipril. It is created by eHealthMe based on reports of 1,412 people who take the same drugs from the FDA, and is updated regularly.
What is Docetaxel?
Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.
What is Ramipril?
Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,412 people who take Docetaxel and Ramipril together, and have interactions are studied.
What are the common drug interactions of Docetaxel and Ramipril, by gender? *
What are the common drug interactions of Docetaxel and Ramipril, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Docetaxel and Ramipril?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Docetaxel and Ramipril:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Docetaxel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ramipril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Docetaxel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ramipril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
- Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on docetaxel and ramipril (the active ingredients of Docetaxel and Ramipril, respectively), and Docetaxel and Ramipril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cataplexy and drugs of ingredients of fenofibrate - 4 seconds ago
- Could Tracleer cause Presyncope? - 6 seconds ago
- Drug interactions of Amlodipine and Simponi - 7 seconds ago
- Could Lansoprazole cause Pericarditis? - 14 seconds ago
- Drug interactions of Diovan and Xarelto - 21 seconds ago
- Could Lopressor cause Cardiac Failure Congestive? - 21 seconds ago
- Drug interactions of Methotrexate and Adriamycin Pfs - 24 seconds ago
- Dexamethasone and Aspartate Aminotransferase Increased for Women aged 60+ - 25 seconds ago
- Could Dulcolax cause White Blood Cell Count Increased? - 25 seconds ago
- Drug interactions of Lotensin and Vioxx - 26 seconds ago